NCT00525460 Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function Status COMPLETED Phase N/A
NCT00523809 Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor Status TERMINATED Phase PHASE2
NCT00523380 Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00522301 Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission Status TERMINATED Phase PHASE2
NCT00520013 Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors Status COMPLETED Phase PHASE2
NCT00517621 Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire Status COMPLETED Phase PHASE2
NCT00516841 A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Status TERMINATED Phase PHASE2
NCT00515372 Depression Treatment and Screening in Ovarian Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00511641 Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer Status UNKNOWN Phase N/A
NCT00507741 Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) Status COMPLETED Phase PHASE2
NCT00504257 Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma Status COMPLETED Phase PHASE2
NCT00501644 Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00499512 Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer Status UNKNOWN Phase N/A
NCT00489359 Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1/PHASE2